Magnetic resonance surveillance reduces mortality in women at high risk of BRCA1 breast cancer: Study

An international study, published in JAMA Oncology, in which the Clinical Oncology group of the Sant Pau Research Institute participated, has revealed that MRI monitoring in women with mutations in the BRCA1 genes significantly reduces breast cancer mortality without the need for preventive mastectomy.

Leave A Comment

Your email address will not be published. Required fields are marked *